• miRview® mets2 / mets
    A cutting-edge molecular test that identifies the primary origin of tumors. The test is designed for cancer patients with an uncertain or unknown origin (Cancer of Unknown Primary -CUP). 
    Basic Information
     Order a test
     
  • miRview® lung2
    A pioneering molecular test that accurately differentiates lung primary tumors into small cell lung cancer (SCLC), carcinoid, squamous non–small cell lung cancer (NSCLC) and non-squamous NSCLC.
    Basic Information
     Order a test
     
  • miRview® squamous2
    An innovative molecular test that accurately differentiates squamous from nonsquamous non–small cell lung cancer (NSCLC).
    Click here for new study findings
     Order a test
     
  • miRview® meso2
    The first single test that accurately differentiates malignant pleural mesothelioma from carcinomas in the lung and pleura.
    Rosetta Genomics Signs Marketing Agreement with PACE claims services for miRview® meso
     Order a test
     
  • miRview® kidney2
    A novel molecular test that accurately differentiates the 4 main histological types of primary kidney tumors: namely, benign oncocytoma and the 3 subtypes of renal cell carcinoma (RCC): clear cell, papillary and chromophobe.